Gene · 5094
PCBP2: poly(rC) binding protein 2
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. PCBP2: poly(rC) binding protein 2. Genes, record 5094. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/5094
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q15366 | Poly(rC)-binding protein 2 | 365 | 5 | Ensembl, GeneID, HGNC |
Source UniProt
Patents23
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 58363 | Q15366 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 13548 | Q15366 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 15474 | Q15366 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 13548 | Q15366 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 15474 | Q15366 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 15474 | Q15366 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 15313 | Q15366 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 64697 | Q15366 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 167668 | Q15366 | Espacenet |
| JP 2021536249 A | 2021-12-27 | 15667 | Q15366 | Espacenet |
1 to 10 of 23
See all 23 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,181
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | PCBP2 papers | Newest fiscal year |
|---|---|---|---|
| ZIADK054510 | Identification of human genes of iron homeostasis | 12 | 2025 |
| P30CA062203 | Cancer Center Support Grant | 7 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 6 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 4 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 4 | 2025 |
| P30CA125123 | Baylor College of Medicine Cancer Center - Cancer Center Support Grant | 4 | 2025 |
| P20GM103427 | Nebraska Research Network in Functional Genomics | 3 | 2025 |
| P30CA043703 | Case Comprehensive Cancer Center Support Grant | 3 | 2025 |
| P30CA076292 | Moffitt Cancer Center Support Grant | 3 | 2025 |
| R01AR049737 | Epidermal Signaling Regulators | 3 | 2025 |
1 to 10 of 1,181Source NIH's project files
See all 1,181 nih grantsPapers1,668
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular Vesicles: Classification, Biological Functions, Diseases, and Therapeutic Opportunities. | MedComm (2020) | 2026 | 42769510 | PubTator, text mining | PubMed |
| PCBP2 facilitates miR-93-5p-mediated repression of GDF11 in HCC cell lines. | Mol Ther Nucleic Acids | 2026 | 42732236 | PubTator, text mining | PubMed |
| RETRACTION: PCBP2 Promotes the Development of Glioma by Regulating FHL3/TGF-β/Smad Signaling Pathway. | J Cell Physiol | 2026 | 42627232 | PubTator, text mining | PubMed |
| N6-methyladenosine-modified circLPAR3 drives docetaxel resistance in prostate cancer by suppressing ferroptosis through the PCBP2/CHAC1 axis. | Genes Dis | 2026 | 42621305 | PubTator, text mining | PubMed |
| TDP-43 drives ferroptosis evasion by modulating PCBP1/PCBP2 axis to promote lung adenocarcinoma growth. | Redox Biol | 2026 | 42585793 | PubTator, text mining | PubMed |
| The lncRNA Gm16685 / MITA1 modulates inflammatory astrocyte reactivity through PCBP2 associated regulation of IKKβ signaling. | bioRxiv | 2026 | 42465384 | PubTator, text mining | PubMed |
| EGFR mimotope alleviates renal fibrosis by promoting EGFR/RPL6/PCBP2 ternary complex formation. | NPJ Vaccines | 2026 | 42399607 | PubTator, text mining | PubMed |
| A novel role of circCPSF6 regulating antiviral innate immunity via miR-665 and PCBP2-IPS-1 axis in IAV infection. | Mol Ther Nucleic Acids | 2026 | 42367247 | PubTator, text mining | PubMed |
| Radiation-Induced Tumor-Intrinsic LTβR N-Glycosylation Suppresses Pyroptosis Through TRIM28-Mediated PCBP2 SUMOylation to Promote Gastric Cancer Radioresistance. | Adv Sci (Weinh) | 2026 | 42325190 | PubTator, text mining | PubMed |
| A P-body-related risk score predicts prognosis and immune microenvironment in lung adenocarcinoma. | Transl Cancer Res | 2026 | 42305460 | PubTator, text mining | PubMed |
1 to 10 of 1,668
See all 1,668 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/5094
GET https://conductscience.org/api/genes/v1/5094/patents?page=2